Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Opinion and Comment
Nature Biotechnology 24, 1105–1107 (1 September 2006) | doi:10.1038/nbt0906-1105
Impact of microarray data quality on genomic data submissions to the FDA
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
